zoledronic acid has been researched along with Hypoparathyroidism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarado, M; Bueno, S; González, L; Ramírez, M; Sierra, M | 1 |
| Epperla, N; Pathak, R | 1 |
2 other study(ies) available for zoledronic acid and Hypoparathyroidism
| Article | Year |
|---|---|
Hypercalcemia of Malignancy in a Patient with Hypoparathyroidism: A Complicated but Treatable Condition.
Topics: Bone Density Conservation Agents; Calcitriol; Diphosphonates; Eye Neoplasms; Humans; Hypercalcemia; Hypoparathyroidism; Male; Melanoma; Middle Aged; Noonan Syndrome; Zoledronic Acid | 2019 |
Hypocalcemia Secondary to Zoledronate Therapy in a Patient With Low Vitamin D Level.
Topics: Bone Density Conservation Agents; Calcium; Diphosphonates; Humans; Hypocalcemia; Hypoparathyroidism; Imidazoles; Lung Neoplasms; Male; Middle Aged; Risk Factors; Small Cell Lung Carcinoma; Vitamin D Deficiency; Zoledronic Acid | 2015 |